메뉴 건너뛰기
Transplantation Proceedings
Volumn 43, Issue 6, 2011, Pages 2439-2440
Present and future of immunosuppressive therapy in kidney transplantation
Author keywords

[No Author keywords available]
Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; DACLIZUMAB; EVEROLIMUS; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS;
EID: 80051703065     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.06.025     Document Type: Article
Times cited : (34)
References (7)
  • 1
    • 33744473322 scopus 로고    scopus 로고
    • Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: A systematic review and meta-analysis of randomized trials
    • A.C. Webster, V.W. Lee, and J.R. Chapman Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials Transplantation 81 2006 1234
    • (2006) Transplantation , vol.81 , pp. 1234
    • Webster, A.C.1    Lee, V.W.2    Chapman, J.R.3
  • 2
    • 19244366021 scopus 로고    scopus 로고
    • Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients
    • H.J. Eisen, E.M. Tuzcu, and R. Dorent Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients N Engl J Med 349 2003 847
    • (2003) N Engl J Med , vol.349 , pp. 847
    • Eisen, H.J.1    Tuzcu, E.M.2    Dorent, R.3
  • 3
    • 67649958571 scopus 로고    scopus 로고
    • Current status and challenges associated with targeting mTOR for cancer therapy
    • R.J. Dowling, M. Pollak, and N. Sonenberg Current status and challenges associated with targeting mTOR for cancer therapy BioDrugs 23 2009 77
    • (2009) BioDrugs , vol.23 , pp. 77
    • Dowling, R.J.1    Pollak, M.2    Sonenberg, N.3
  • 4
    • 37349034394 scopus 로고    scopus 로고
    • Reduced exposure to calcineurin inhibitors in renal transplantation
    • H. Ekberg, H. Tedesco-Silva, and A. Demirbas Reduced exposure to calcineurin inhibitors in renal transplantation N Engl J Med 357 2007 2562
    • (2007) N Engl J Med , vol.357 , pp. 2562
    • Ekberg, H.1    Tedesco-Silva, H.2    Demirbas, A.3
  • 5
    • 28544445337 scopus 로고    scopus 로고
    • Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal function
    • G. Russ, G. Segoloni, and R. Oberbauer Superior outcomes in renal transplantation after early cyclosporine withdrawal and sirolimus maintenance therapy, regardless of baseline renal function Transplantation 80 2005 1204
    • (2005) Transplantation , vol.80 , pp. 1204
    • Russ, G.1    Segoloni, G.2    Oberbauer, R.3
  • 6
    • 73849119625 scopus 로고    scopus 로고
    • Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: A multicenter, randomized, controlled trial
    • M. Salvadori, M.P. Scolari, and E. Bertoni Everolimus with very low-exposure cyclosporine a in de novo kidney transplantation: a multicenter, randomized, controlled trial Transplantation 88 2010 1194
    • (2010) Transplantation , vol.88 , pp. 1194
    • Salvadori, M.1    Scolari, M.P.2    Bertoni, E.3
  • 7
    • 23944502334 scopus 로고    scopus 로고
    • Co-stimulation blockade with belatacept in renal transplantation
    • F. Vincenti, C. Larsen, and A. Durrbach Co-stimulation blockade with belatacept in renal transplantation N Engl J Med 353 2005 770
    • (2005) N Engl J Med , vol.353 , pp. 770
    • Vincenti, F.1    Larsen, C.2    Durrbach, A.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.